These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 18721117)
1. Clinical development of metformin extended-release tablets for type 2 diabetes: an overview. Schwartz SL; Gordi T; Hou E; Cramer M; Heritier M; Cowles VE Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1235-43. PubMed ID: 18721117 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of once- or twice-daily extended release metformin compared with thrice-daily immediate release metformin in type 2 diabetes mellitus. Bhansali A; Masoodi SR J Assoc Physicians India; 2005 May; 53():441-5. PubMed ID: 16124352 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients. Li J; Klemm K; O'Farrell AM; Guler HP; Cherrington JM; Schwartz S; Boyea T Curr Med Res Opin; 2010 Aug; 26(8):2003-10. PubMed ID: 20583949 [TBL] [Abstract][Full Text] [Related]
4. Metformin extended release for the treatment of type 2 diabetes mellitus. Schwartz SL; Wu JF; Berner B Expert Opin Pharmacother; 2006 Apr; 7(6):803-9. PubMed ID: 16556094 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and dose proportionality of extended-release metformin following administration of 1000, 1500, 2000 and 2500 mg in healthy volunteers. Cullen E; Liao J; Lukacsko P; Niecestro R; Friedhoff L Biopharm Drug Dispos; 2004 Sep; 25(6):261-3. PubMed ID: 15334625 [TBL] [Abstract][Full Text] [Related]
12. Investigation of the pharmacokinetic and pharmacodynamic interactions between memantine and glyburide/metformin in healthy young subjects: a single-center, multiple-dose, open-label study. Rao N; Chou T; Ventura D; Abramowitz W Clin Ther; 2005 Oct; 27(10):1596-606. PubMed ID: 16330295 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and bioavailability of a metformin/glyburide tablet administered alone and with food. Marathe PH; Arnold ME; Meeker J; Greene DS; Barbhaiya RH J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1494-502. PubMed ID: 11185672 [TBL] [Abstract][Full Text] [Related]
14. Population exposure-response modeling of metformin in patients with type 2 diabetes mellitus. Hong Y; Rohatagi S; Habtemariam B; Walker JR; Schwartz SL; Mager DE J Clin Pharmacol; 2008 Jun; 48(6):696-707. PubMed ID: 18372428 [TBL] [Abstract][Full Text] [Related]
15. Effect of food on the pharmacokinetics of a vildagliptin/metformin (50/1000 mg) fixed-dose combination tablet in healthy volunteers. He YL; Flannery B; Campestrini J; Leon S; Zinny MA; Ligueros-Saylan M; Jarugula V Curr Med Res Opin; 2008 Jun; 24(6):1703-9. PubMed ID: 18471347 [TBL] [Abstract][Full Text] [Related]
16. Sitagliptin/metformin (Janumet) for type 2 diabetes. Med Lett Drugs Ther; 2007 Jun; 49(1262):45-7. PubMed ID: 17541377 [No Abstract] [Full Text] [Related]
17. Pharmacokinetics of metformin gastric-retentive tablets in healthy volunteers. Gusler G; Gorsline J; Levy G; Zhang SZ; Weston IE; Naret D; Berner B J Clin Pharmacol; 2001 Jun; 41(6):655-61. PubMed ID: 11402634 [TBL] [Abstract][Full Text] [Related]
18. Saxagliptin/metformin (kombiglyze XR) for type 2 diabetes. Med Lett Drugs Ther; 2011 Mar; 53(1360):21-2. PubMed ID: 21412207 [No Abstract] [Full Text] [Related]
19. [Formulation by design of experiments of immediate release tablets with metformin hydrochloride and glibenclamide]. Potur RG; GafiĊ£anu E Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1219-26. PubMed ID: 21500483 [TBL] [Abstract][Full Text] [Related]
20. Overview of metformin: special focus on metformin extended release. Ali S; Fonseca V Expert Opin Pharmacother; 2012 Aug; 13(12):1797-805. PubMed ID: 22775758 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]